Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Review: nonalcoholic steatohepatitis

J Ludwig1, D B McGill, K D Lindor

  • 1Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Journal of Gastroenterology and Hepatology
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OrthoRefine: automated enhancement of prior ortholog identification via synteny.

BMC bioinformatics·2024
Same author

A flexible proton beam imaging energy spectrometer (PROBIES) for high repetition rate or single-shot high energy density (HED) experiments (invited).

The Review of scientific instruments·2023
Same author

A critical evaluation of the material properties and clinical suitability of in-house printed and commercial tooth replicas for endodontic training.

International endodontic journal·2020
Same author

Long spin-flip time and large Zeeman splitting of holes in type-II ZnTe/ZnSe submonolayer quantum dots.

Journal of applied physics·2019
Same author

Treatment of old neglected dislocations of the AC-joint with residual instability and/or secondary osteoarthrosis.

Der Orthopade·2017
Same author

Surgical treatment of lumbar disc herniation. Indication and methods.

Der Orthopade·2017

Nonalcoholic steatohepatitis (NASH) is a common liver disease often linked to obesity and diabetes. Its progression varies, but treatments remain limited, emphasizing gradual weight loss and diabetes management.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Nonalcoholic steatohepatitis (NASH) is a liver condition associated with obesity, diabetes mellitus, hyperlipidemia, and hyperglycemia.
  • While often linked to female gender, obesity, and diabetes, these associations may not be absolute, and an underlying cause is not always identifiable.
  • The natural history of NASH is not fully understood, with a spectrum of presentations from non-progressive fatty liver to severe steatohepatitis with hepatic necrosis.

Purpose of the Study:

  • To review the clinicopathological entity of Nonalcoholic steatohepatitis (NASH).
  • To discuss the spectrum of disease progression and clinical significance.
  • To outline current and potential treatment strategies for NASH.

Main Methods:

Related Experiment Videos

  • Literature review of Nonalcoholic steatohepatitis (NASH).
  • Analysis of clinicopathological features and disease progression.
  • Evaluation of current treatment modalities and ongoing research.

    • Main Results:

    • NASH encompasses a range of liver conditions, from simple fatty liver to progressive fibrosis and cirrhosis.
    • The slowly progressive form of NASH is common, potentially leading to cirrhosis and hepatocellular carcinoma (HCC).
    • Subfulminant NASH is rare due to increased awareness of risks associated with rapid weight loss.

    Conclusions:

    • Gradual weight loss is the primary recommended therapy for obese patients with NASH, though adherence is challenging.
    • Management includes avoiding precipitous weight loss and controlling diabetes mellitus.
    • Treatment for advanced NASH cirrhosis is similar to other cirrhosis types, including liver transplantation; UDCA is under investigation.